The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of Tarivid (Ofloxacin 200mg), a widely used antibacterial medication.
The agency said the World Health Organisation (WHO) Global Surveillance and Monitoring System (GSMS) would be informed of the ban to have it flagged internationally as a counterfeit medication.
In its public alert numbered 21/2025, titled ‘Alert on the Report of Unregistered Tarivid (Ofloxacin 200mg) found in Nigeria’ and released on Tuesday, NAFDAC stated that the product was found on the shelf of a pharmacy in Onipan, Shomolu Local Government Area of Lagos State.
Tarivid, manufactured by a global pharmaceutical company, Sanofi, is a brand of Ofloxacin, a broad-spectrum antibacterial agent used in the treatment of respiratory tract, urinary tract, kidneys, skin, and soft tissue infections.
